Furthermore, we identify downstream signaling pathways, including the Focal Adhesion Kinase (FAK) pathway, that are altered in non-invasive breast cancer cells after co-incubation with EVs from invasive breast cancer cells and from YWBC patients, which may serve as targets for intervention. This evidence concerns the gene PTK2 and breast carcinoma.